4 results match your criteria: "Affiliated Hospital of Hubei University of Medicine Shiyan 442000[Affiliation]"
Am J Cancer Res
August 2022
Department of Organ Transplantation, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang 330006, Jiangxi, China.
Cathepsin A (CTSA) is overexpressed in various types of cancer and is linked to poor clinical outcomes. However, the clinical application of CTSA in HCC has not been explored. In this study, we examined the protein level of CTSA in the archived HCC samples from 161 patients by Immunohistochemistry (IHC).
View Article and Find Full Text PDFAm J Transl Res
September 2021
Department of Cardiovascular Medicine, Taihe Hospital (Affiliated Hospital of Hubei University of Medicine) Shiyan 442000, Hubei Province, China.
Objective: This study aimed to investigate the value of Gensini score and interleukin-1 receptor antagonist (IL-1ra) in assessing the condition and prognosis of patients with coronary heart disease (CHD).
Methods: According to their condition, 175 patients were divided into stable angina group (SA, 60 cases), unstable angina group (UA, 60 cases) and acute myocardial infarction group (AMI, 55 cases). The Gensini score, GRACE score, IL-1ra and troponin (Tn) were compared in the three groups.
Am J Transl Res
June 2021
Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University Wuhan 430060, Hubei, P. R. China.
The aim of this study was to evaluate factors affecting the recurrence of positive RT-PCR results. By performing a retrospective analysis, we evaluated the clinical data of recurrent positive coronavirus disease 2019 (COVID-19) patients in multiple medical institutions in Wuhan. We recruited COVID-19 patients who were hospitalized from January 1 to March 10, 2020, in three tertiary hospitals in Wuhan, met the discharge criteria and received at least one additional nucleic acid test before leaving the hospital.
View Article and Find Full Text PDFZhongguo Zhong Yao Za Zhi
January 2021
School of Traditional Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100029, China Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine Shiyan 442000, China.
To systematically evaluate the clinical efficacy and safety of Danhong Injection combined with conventional therapy in improving diabetes mellitus complicated with coronary heart disease. Based on the online literature database(CNKI, Wanfang, VIP, PubMed, Web of Science, Cochran Library), the Chinese and English papers about the randomized controlled trial(RCT) of Danhong Injection in the treatment of diabetes mellitus complicated with coronary heart disease were searched comprehensively from the establishment of the databases to January 1, 2020. The papers were screened strictly according to the inclusion and exclusion criteria.
View Article and Find Full Text PDF